Back

Contrast volume to creatinine clearance ratio, a strong predictor of contrast induced nephropathy in patients undergoing percutaneous intervention

18 May 2025 (10:00 - 11:00)
Organised by: Logo
Congress Presentation Part of: ePosters in coronary artery disease (chronic) / chronic coronary syndromes (2) Revascularisation HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Francisco Rodrigues Santos

Hospital Sao Teotonio, Viseu (Portugal)

7 More presentations in this session

Presentation thumbnail
Use of ECG and other clinical parameters to severe left ventricular systolic dysfunction
Doctor I. Chung (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Predictive role of pretest factors and cardiovascular risk factors in obstructive coronary artery disease
Doctor T. Phan (Ho Chi Minh, VN)
Abstract Slides Video
Presentation thumbnail
Acute coronary syndrome in the oldest old: insights into clinical profiles and symptoms
Miss J. Conde Goncalves (Porto, PT)
Abstract Slides Video
Presentation thumbnail
The impact of ABCDE stress echocardiography results with exercise on the management of patients with coronary artery disease
Doctor D. Abdulloev (Dushanbe, TJ)
Abstract Slides Video
Presentation thumbnail
Assessing intermediate coronary lesions: comparing pressure wire and angiography for revascularization guidance before transcatheter aortic valve replacement
Doctor T. Pereira dos Santos (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in coronary artery disease (chronic) / chronic coronary syndromes (2)

The Event

Event poster

Heart Failure 2025

18 May 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Rethinking acute kidney injury risk: beyond contrast volume in acute myocardial infarction
thumbnail
Congress Presentation
The use of allopurinol in prophylaxis against contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Impact of zero-contrast percutaneous coronary intervention on renal function in chronic phase

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources